BAI Wen1, YANG Jia-yi1, ZHANG Yun-ling2, et al. Regulation of therapy of dispelling toxin and dredging collaterals on PKCδ/MARCKS signal pathway in rats with acute cerebral ischemia[J]. Journal of Beijing University of traditional Chinese Medicine, 2010, 33(2): 88-93.
BAI Wen1, YANG Jia-yi1, ZHANG Yun-ling2, et al. Regulation of therapy of dispelling toxin and dredging collaterals on PKCδ/MARCKS signal pathway in rats with acute cerebral ischemia[J]. Journal of Beijing University of traditional Chinese Medicine, 2010, 33(2): 88-93.DOI:
Objective To study the regulation of Kudiezi Injection with the actions of dispelling toxin and dredging collaterals on PKCδ/MARCKS signal pathway in rats with acute cerebral ischemia
and investigate the brain protective mechanism of the therapy of dispelling toxin and dredging collaterals.Methods The rat model of local cerebral ischemia induced by middle cerebral artery occlusion(MCAO) was established by using modified Zea Longa suture.All rats were randomly divided into the control group
model group
Chinese medicine group(with Kudiezi Injection) and Western medicine group(with hydroxyfasudil injection).The neurological functional deficit score was reviewed in all groups 12 hours after model establishment.The pathology of cerebral tissue was observed by the light microscope after HE staining.The expressions of PKCδ
p-PKCδ
MARCKS and p-MARCKS were detected by using immunohistochemistry and Western blotting
and the expressions of PKCδ and MARCKS-mRNA were detected by using real-time fluorescence quantitative polymerase chain reaction(RT-PCR).Results Kudiezi Injection decreased significantly the neurological functional deficit score(P<0.01)
alleviated the pathological changes of cerebral ischemia
and reduced the expressions of PKCδ
MARCKS and MARCKS-mRNA(P<0.05
P<0.01) in rats with acute cerebral ischemia.Conclusion The therapy of dispelling toxin and dredging collaterals has a brain protective effect in the treatment of acute cerebral ischemia
and the mechanism may be related to that the therapy can inhibit the activity of PKCδ/MARCKS signal pathway in ischemia brain.